Kinerja vs S&P 500

03
Dilacak Q1 2025–Q2 2026 +295.5%
Total imbal hasil S&P 500 (jendela yang sama) +37.0%
Imbal hasil berlebih +258.5%

Tahunan: +200.6% · S&P 500: +28.7%

Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.

Cakupan yang dapat dihargai: 95,3% · Opsi dikecualikan: 0,0%

Rincian sektor

04
Healthcare 98,6%
Lainnya/Tidak terpetakan 1,4%

Portofolio lengkap 33 posisi

05
Tipe Rentetan Tren 8 kuartal
APGE Apogee Therapeutics, Inc. - Common Stock $1.127.318.496 34,18% 8.493.321 $412.435.667
ORKA Oruka Therapeutics, Inc. - Common Stock $394.805.893 11,97% 4.148.428 $191.325.500
ERAS Erasca, Inc. - Common Stock $327.777.996 9,94% 17.891.812 $62.704.098 Naik ×1
SYRE Spyre Therapeutics, Inc. - Common Stock $265.048.073 8,04% 2.985.448 $79.154.076 Turun ×1
DNTH Dianthus Therapeutics, Inc. - Common Stock $115.026.400 3,49% 1.180.000 $16.000.800
OCUL Ocular Therapeutix, Inc. - Common Stock $101.606.813 3,08% 10.346.926 $13.968.350
GLTO Galecto, Inc. - Common Stock $93.729.506 2,84% 3.603.595 $396.395
SVRA Savara, Inc. - Common Stock $90.835.009 2,75% 14.745.943 $15.812.561 Naik ×1
JBIO Jade Biosciences, Inc. - Common Stock $71.556.488 2,17% 3.220.364 $26.310.374
COGT Cogent Biosciences, Inc. - Common Stock $63.551.824 1,93% 1.642.166 $-13.428.176 Turun ×1
VRDN Viridian Therapeutics, Inc. - Common Stock $59.847.935 1,81% 3.257.917 $-16.097.853 Turun ×1
VOR Vor Biopharma Inc. - Common Stock $55.998.047 1,70% 3.041.719 $1.733.780
DYN Dyne Therapeutics, Inc. - Common Stock $48.282.608 1,46% 2.173.913 $8.869.565
MAZE Maze Therapeutics, Inc. - Common Stock $47.804.695 1,45% 1.602.034 $-16.020
RLMD Relmada Therapeutics, Inc. - Common Stock $47.362.591 1,44% 6.844.305 $13.652.666 Naik ×1
ORIC Oric Pharmaceuticals, Inc. - Common Stock $46.783.055 1,42% 4.319.765 $-7.948.368
CBIO Crescent Biopharma, Inc. - Common Stock $38.404.368 1,16% 2.133.576 $-789.423
ZURA Zura Bio Limited - Class A Ordinary shares $37.966.441 1,15% 6.434.990 $-321.750
ANL Adlai Nortye Ltd. - American Depositary Shares $36.946.407 1,12% 3.212.731 $14.714.308
ELVN Enliven Therapeutics, Inc. - Common Stock $26.711.298 0,81% 526.331 $-40.960.877 Turun ×2
HELP Cybin Inc. - Common Stock $25.459.433 0,77% 3.851.654 $6.971.494
CGEM Cullinan Therapeutics, Inc. - Common Stock $25.129.163 0,76% 1.379.965 $5.519.860
IPSC Century Therapeutics, Inc. - Common Stock $21.304.347 0,65% 8.695.652 $1.652.173
ARTV Artiva Biotherapeutics, Inc. - Common Stock $19.822.881 0,60% 2.043.596 $9.457.257 Naik ×1
CTMX CytomX Therapeutics, Inc. - Common Stock $18.682.965 0,57% 4.982.124 $-28.233.018 Turun ×2
ACHV Achieve Life Sciences, Inc. - Common Shares $17.964.239 0,54% 2.751.032 Naik ×1
Penerbit tidak dikenal (CUSIP: 698955101) $17.106.250 0,52% 625.000 Naik ×1
SRZN Surrozen, Inc. - Common Stock $16.424.559 0,50% 632.931 $-2.012.721
KRRO Korro Bio, Inc. - Common Stock $13.305.210 0,40% 1.009.500 $1.877.670
ANRO Alto Neuroscience, Inc. Common Stock $13.195.000 0,40% 500.000 $1.955.000
XFOR X4 Pharmaceuticals, Inc. - Common Stock $9.032.962 0,27% 1.934.253 $7.667.894 Naik ×1
Penerbit tidak dikenal (CUSIP: G75226103) $3.210.000 0,10% 300.000 Naik ×1
INM InMed Pharmaceuticals Inc. - Common Shares $50.662 0,00% 32.685 Naik ×1

Taruhan baru terbesar

09

Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.

SekuritasNilaiSaham% dari portofolio
ACHV $17.964.239 2.751.032 0,54%
Penerbit tidak dikenal (CUSIP: 698955101) $17.106.250 625.000 0,52%
Penerbit tidak dikenal (CUSIP: G75226103) $3.210.000 300.000 0,10%
INM $50.662 32.685 0,00%

Penggerak teratas (QoQ)

10
SekuritasAksiSaham ΔNilai Δ
APGE Hanya pergerakan harga +0 +$412.4M
ORKA Hanya pergerakan harga +0 +$191.3M
SYRE Dipangkas -700K +$79.2M
ERAS Beli lebih banyak +1.5M +$62.7M
ELVN Dipangkas -1.2M -$41.0M
CTMX Dipangkas -5.0M -$28.2M
JBIO Hanya pergerakan harga +0 +$26.3M
VRDN Dipangkas -625K -$16.1M
DNTH Hanya pergerakan harga +0 +$16.0M
SVRA Beli lebih banyak +1.0M +$15.8M

Posisi yang keluar

11

Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan

Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.

SekuritasKuartalSaham sebelumnyaNilai sebelumnyaHarga sejak keluar
MTSR 31 Des. 2025 3.750.662 $196.272.142 Tidak lagi dilacak
KALV 30 Juni 2026 6.474.485 $130.331.383 Tidak lagi dilacak
CDTX 31 Des. 2025 946.788 $90.664.419 Tidak lagi dilacak
ABVX 31 Des. 2025 576.729 $48.964.292 -32,0%
PRAX 30 Juni 2025 989.985 $37.490.732 574,3%
ENGN 30 Juni 2026 4.771.414 $32.493.329 8,1%
UPB 31 Maret 2026 1.169.298 $31.746.441 -46,1%
TENX 30 Juni 2026 1.675.262 $26.787.439 -86,5%
ATXS 31 Des. 2025 2.457.348 $17.889.493 Tidak lagi dilacak
PHVS 31 Des. 2025 674.599 $16.831.245 9,9%
SEPN 30 Juni 2026 506.056 $12.160.526 13,1%
SLDB 30 Juni 2025 2.481.400 $9.181.180 45,0%
PCSC 31 Des. 2025 750.000 $7.950.000 Tidak lagi dilacak
TRVI 30 Juni 2025 615.506 $3.871.533 150,8%
TENX 31 Des. 2025 437.708 $3.330.958 -83,9%
APLT 30 Juni 2025 5.567.709 $2.722.053 Tidak lagi dilacak
FDMT 30 Juni 2025 677.600 $2.188.648 248,2%
MRSN 30 Juni 2025 3.574.325 $1.230.283 Tidak lagi dilacak
IPSC 30 Juni 2025 2.498.069 $1.189.081 164,8%
TNYA 30 Juni 2025 1.555.556 $886.822 -7,7%
CASIF 31 Maret 2026 987.259 $839.170 Tidak lagi dilacak
GLYC 30 Juni 2025 3.000.000 $630.000 Tidak lagi dilacak
TIL 30 Juni 2025 33.177 $575.953 -66,6%